“New medical treatments for cancer, cardiovascular disease and rare conditions could flow from a multi-million euro research award jointly funded by Science Foundation Ireland (SFI) and pharma giant Pfizer …” (more)
[Dick Ahlstrom, Irish Times, 13 April]
Tags: Pfizer, RCSI, SFI, UCC, UCD
This entry was posted on Thursday, April 14th, 2016 at 05:51 and is filed under Research.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.
